Cullinan Oncology Inc. (CGEM)
undefined
undefined%
At close: undefined
11.75
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - 18.94M - - -
Cost of Revenue 310.00K 93.00K 53.00K 62.00K 70.00K 43.00K
Gross Profit -310.00K -93.00K 18.89M -62.00K -70.00K -43.00K
Operating Income -191.09M 144.65M -67.95M -60.34M -22.27M -14.59M
Interest Income 21.63M 6.61M 477.00K 888.00K 620.00K 397.00K
Pretax Income -169.22M 151.32M -67.48M -59.46M -21.65M -14.19M
Net Income -153.16M 111.21M -65.04M -50.85M -20.04M -14.19M
Selling & General & Admin 42.49M 40.19M 29.15M 17.12M 5.48M 5.00M
Research & Development 148.16M 91.95M 57.75M 43.21M 16.79M 9.58M
Other Expenses 440.00K 57.00K -8.00K -11.00K -4.00K -
Operating Expenses 191.09M 132.14M 86.90M 60.34M 22.27M 14.59M
Interest Expense - - - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 191.09M 132.14M 86.90M 60.34M 22.27M 14.59M
Income Tax -14.12M 42.12M -2.44M -8.61M -1.62M 397.00K
Shares Outstanding (Basic) 41.51M 45.16M 44.29M 43.52M 43.52M 11.45M
Shares Outstanding (Diluted) 41.55M 46.64M 44.29M 43.52M 43.52M 11.45M
EPS (Basic) -3.69 2.46 -1.47 -1.17 -0.46 -1.24
EPS (Diluted) -3.69 2.38 -1.47 -1.17 -0.46 -1.24
EBITDA -190.34M 151.41M -67.90M -60.27M -22.20M -14.54M
Depreciation & Amortization 310.00K 93.00K 53.00K 62.00K 70.00K 43.00K